Ryan Peckner

Title: Ryan Peckner: Innovator in Protease Variants

Introduction

Ryan Peckner is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of protease variants and their applications in treating various disorders. With a total of 2 patents, his work has the potential to impact the medical community significantly.

Latest Patents

Ryan Peckner's latest patents include innovative approaches to protease variants. The first patent, titled "Protease variants and uses thereof," describes polypeptides and molecules that exhibit protease activity alongside a variant Fc molecule. This invention also encompasses pharmaceutical compositions that can be utilized to treat disorders, such as IgG mediated disorders. The second patent, "Variant IgG Fc polypeptides and uses thereof," focuses on variant IgG Fc polypeptides and dimeric molecules. This patent outlines pharmaceutical compositions and methods aimed at targeting cells to modulate their activity, which can be beneficial in treating autoimmune disorders or cancers.

Career Highlights

Ryan Peckner is currently associated with Seismic Therapeutic, Inc., where he continues to push the boundaries of innovation in biotechnology. His work is characterized by a commitment to developing solutions that address critical health challenges.

Collaborations

Ryan collaborates with talented individuals in his field, including Nathan Higginson-Scott and Yanfeng Zhou. These partnerships enhance the research and development efforts at Seismic Therapeutic, Inc.

Conclusion

In summary, Ryan Peckner is a distinguished inventor whose work in protease variants holds promise for advancing medical treatments. His contributions to biotechnology are noteworthy and reflect his dedication to innovation in the field.